首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody
产品名称:
PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody
产品类别:
抗体
产品编号:
128011
产品应用:
128011
[价格]
规格 价格 库存
25µg ¥ 1692 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  2. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  3. Sch?dlich IS, et al. 2022. iScience. 25:104470. PubMed
  4. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  5. Ballesteros I, et al. 2014. J Vis Exp. 94: 52031. PubMed
  6. Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
  7. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  8. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  9. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  10. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  11. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  12. Israelow B, et al. 2020. bioRxiv. . PubMed
  13. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  14. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  15. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  16. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  17. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  18. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  19. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  20. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  21. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  22. Demars A, et al. 2021. PLoS Pathog. 17:e1009887. PubMed
  23. Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
  24. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  25. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  26. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  27. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  28. Han YH, et al. 2021. Science. 373:. PubMed
  29. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  30. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  31. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  32. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  33. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  34. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  35. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  36. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  37. Honarpisheh P, et al. 2020. J Neuroinflammation. 0.9625. PubMed
  38. Tanaka T, et al. 2015. J Immunol. 194:2004. PubMed
  39. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  40. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  41. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  42. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  43. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  44. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  45. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  46. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  47. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  48. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  49. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  50. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  51. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  52. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  53. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  54. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  55. Blriot C, et al. 2021. Immunity. :. PubMed
  56. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  57. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  58. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  59. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  60. Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
  61. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  62. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  63. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  64. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  65. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  66. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  67. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  68. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  69. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  70. Budai Z, et al. 2021. Cells. 10:. PubMed
  71. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
  72. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  73. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  74. Klein O, et al. 2019. J Allergy Clin Immunol. 144:1074. PubMed
  75. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  76. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  77. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  78. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  79. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  80. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  81. Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed
  82. Yajjala V, et al. 2016. J Immunol. 196: 4196 - 4203. PubMed
  83. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  84. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
  85. Walsh CM, et al. 2019. Elife. 8:e48448. PubMed
  86. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  87. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  88. Freed-Pastor WA, et al. 2021. Cancer Cell. :. PubMed
  89. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  90. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  91. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  92. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  93. Ikezu S, et al. 2021. Mol Psychiatry. 26:1808. PubMed
  94. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  95. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  96. Valdearcos M et al. 2017. Cell metabolism. 26(1):185-197 . PubMed
  97. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  98. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  99. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  100. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  101. Joshi JC, et al. 2020. Cell Rep. 30:4096. PubMed
  102. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  103. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  104. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  105. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  106. Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
RRID
AB_1659242 (BioLegend Cat. No. 128011) AB_1659241 (BioLegend Cat. No. 128012)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线